- €3.42bn
- €4.43bn
- €1.99bn
- 75
- 26
- 44
- 44
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 17.89 | ||
PEG Ratio (f) | 0.76 | ||
EPS Growth (f) | 30.57% | ||
Dividend Yield (f) | 1.44% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.38 | ||
Price to Tang. Book | 19.04 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.71 | ||
EV to EBITDA | 11.01 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 8.58% | ||
Return on Equity | 9.02% | ||
Operating Margin | 10.72% |
Financial Summary
Year End 30th Nov | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 1,392.26 | 1,418.79 | 1,498.01 | 1,817.09 | 1,990.49 | 2,130.77 | 2,385.49 | 7.79% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -7.74 | +21.21 | -6.2 | +21 | +8.13 | +33.2 | +27.48 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Directors
- Axel Herberg CSU (63)
- Dietmar Siemssen CMG (58)
- Francesco Grioli VSU (48)
- Bernd Metzner CFO (50)
- Lukas Burkhardt MGB (42)
- Andrea Abt IND
- Karin Dorrepaal IND (60)
- Peter Noe IND (64)
- Theodor Stuth IND (68)
- Udo Vetter IND (67)
- Heike Arndt SUB (58)
- Franz Hartinger SUB (61)
- Markus Rocholz SUB (51)
- Paul Schilling SUB (51)
- Katja Schnitzler SUB (40)
- Last Annual
- November 30th, 2023
- Last Interim
- February 29th, 2024
- Incorporated
- April 4th, 2007
- Public Since
- June 11th, 2007
- No. of Employees
- 11,947
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 34,540,000
- Address
- Klaus-Bungert-Strasse 4, DUESSELDORF, 40468
- Web
- https://www.gerresheimer.com/
- Phone
- +49 211618100
- Contact
- Guido Pickert
- Auditors
- Deloitte GmbH
Latest News for GXI
Upcoming Events for GXI
Gerresheimer AG Annual Shareholders Meeting
Dividend For GXIG.DE - 1.2500 EUR
Gerresheimer AG Annual Shareholders Meeting
Q2 2024 Gerresheimer AG Earnings Release
Q3 2024 Gerresheimer AG Earnings Release
Similar to GXI
Aap Implantate AG
XETRA
Bio-Gate AG
XETRA
FAQ
As of Today at 19:09 UTC, shares in Gerresheimer AG are trading at €98.90. This share price information is delayed by 15 minutes.
Shares in Gerresheimer AG last closed at €98.90 and the price had moved by +12.64% over the past 365 days. In terms of relative price strength the Gerresheimer AG share price has outperformed the FTSE Global All Cap Index by +5.75% over the past year.
The overall consensus recommendation for Gerresheimer AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Gerresheimer AG dividend yield is 1.26% based on the trailing twelve month period.
Last year, Gerresheimer AG paid a total dividend of €1.25, and it currently has a trailing dividend yield of 1.26%.Looking ahead, shares in Gerresheimer AG are due to go ex-dividend on 2024-06-06 and the next dividend pay date is 2024-06-10.
Gerresheimer AG are due to go ex-dividend on 2024-06-06 and the next dividend pay date is 2024-06-10. The historic dividend yield on Gerresheimer AG shares is currently 1.26%.
To buy shares in Gerresheimer AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €98.90, shares in Gerresheimer AG had a market capitalisation of €3.42bn.
Here are the trading details for Gerresheimer AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: GXI
Based on an overall assessment of its quality, value and momentum Gerresheimer AG is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Gerresheimer AG is €130.60. That is 32.05% above the last closing price of €98.90.
Analysts covering Gerresheimer AG currently have a consensus Earnings Per Share (EPS) forecast of €4.99 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Gerresheimer AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -10.34%.
As of the last closing price of €98.90, shares in Gerresheimer AG were trading -1.08% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Gerresheimer AG PE ratio based on its reported earnings over the past 12 months is 17.89. The shares last closed at €98.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Gerresheimer AG's management team is headed by:
- Axel Herberg - CSU
- Dietmar Siemssen - CMG
- Francesco Grioli - VSU
- Bernd Metzner - CFO
- Lukas Burkhardt - MGB
- Andrea Abt - IND
- Karin Dorrepaal - IND
- Peter Noe - IND
- Theodor Stuth - IND
- Udo Vetter - IND
- Heike Arndt - SUB
- Franz Hartinger - SUB
- Markus Rocholz - SUB
- Paul Schilling - SUB
- Katja Schnitzler - SUB